Toumai robotic system in uterine cancer surgery: first report of sentinel lymph node dissection in ten steps
PDF
Cite
Share
Request
Video Commentary
E-PUB
20 May 2026

Toumai robotic system in uterine cancer surgery: first report of sentinel lymph node dissection in ten steps

Facts Views Vis ObGyn. Published online 20 May 2026.
1. Gynaecology Oncology Unit, Department of Women’s and Children’s Health Sciences and Public Health, Agostino Gemelli University Hospital Foundation IRCCS, Rome, Italy
2. Research Institute against Digestive Cancer, IRCAD, Strasbourg, France
3. University of Strasbourg, Team Robotics, Data Science and Healthcare Technologies, Strasbourg, France
4. Clinic of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy
No information available.
No information available
Received Date: 03.12.2025
Accepted Date: 27.03.2026
E-Pub Date: 20.05.2026
PDF
Cite
Share
Request

ABSTRACT

Click here to watch the video

Background

In recent years, robotic surgery has gained traction across multiple disciplines, establishing a new minimally invasive paradigm. After the Da Vinci® (Intuitive, Sunnyvale, California) patent expired, several platforms with increasingly digital interfaces entered the market. Robotic surgery may represent a bridge between laparoscopy and digital surgery through interfaces that enable integration with emerging technologies. Among platforms, the Toumai robotic system (Medbot-Microport, Shanghai, China) features a single-arm cart with four arms, a three-dimensional console, and a split-view “picture-in-picture” function enabling communication with image-guided surgical technologies. This functionality is particularly valuable for indocyanine green (ICG)-guided sentinel lymph node (SLN) mapping in gynaecologic oncology.

Objectives

We present for the first time, a step-by-step video demonstration of SLN dissection for endometrial malignancies using the Toumai robotic system.

Participant

A postmenopausal patient with uterine-confined endometrial carcinoma undergoing total hysterectomy, bilateral salpingo-oophorectomy, and bilateral SLN biopsy.

Intervention

The technique includes: 1) ICG injection; 2) robotic trocar placement; 3) docking; 4) pelvic retroperitoneal access; 5) switch to split-view mode; 6) identification of the SLN critical view of safety by developing pararectal and paravesical spaces; 7) introduction of an ICG-capable camera through an accessory trocar; 8) activation of near-infrared visualisation after switching off the robotic light source; 9) SLN identification and dissection; 10) safe extraction. 

Conclusions

The digital interface of the Toumai system integrates adjunctive technologies, illustrating how next-generation robotics expand the feasibility of SLN dissection in endometrial cancers.

What is New?

The Toumai platform enables SLN dissection even in the absence of an in-house integrated ICG endoscopic camera.

Keywords:
Robotic surgical procedures, sentinel lymph node, indocyanine green, endometrial neoplasms, robotics

Acknowledgements

The authors would like to thank the surgical team and operating room staff for their support during the procedure and video recording.

Contributors

Surgical and Medical Practices: M.P., M.C.G., A.N., Concept: M.P., M.D., J.M., D.Q., A.N., Design: M.P., N.B., A.F., F.F., Literature Search: C.I., Writing: M.P., M.C.G., C.I.
Funding: No funding was received for this work.
Competing interests: Francesco Fanfani, MD, serves as Associate Editor for Facts, Views and Vision in ObGyn. He had no involvement in the peer-review of this article and had no access to information regarding its peer-review. The other authors declared that there is no conflict of interest.
Ethical approval: According to institutional policy, formal ethics committee approval is not required for educational video articles describing a single anonymised clinical case performed as part of routine clinical practice.
Informed consent: Written informed consent for participation and video publication was obtained from the patient.
Data sharing: No additional data are available beyond the material presented in the video.
Transparency: The authors affirm that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Suplementary Materials